RenovoRx, Inc.
RNXT
$0.972
-$0.018-1.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.68% | -13.00% | 2.90% | -36.61% | -28.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.53% | -5.20% | -10.10% | -24.07% | -18.11% |
| Operating Income | -48.11% | 5.20% | 10.10% | 24.07% | 18.11% |
| Income Before Tax | 10.81% | -73.89% | -2.66% | 66.96% | -49.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.81% | -73.89% | -2.66% | 66.96% | -49.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.81% | -73.89% | -2.66% | 66.96% | -49.68% |
| EBIT | -48.11% | 5.20% | 10.10% | 24.07% | 18.11% |
| EBITDA | -- | -- | -- | -- | 18.18% |
| EPS Basic | 62.00% | 25.43% | 54.53% | 79.91% | -27.15% |
| Normalized Basic EPS | 62.02% | 25.51% | 54.51% | 79.90% | -27.11% |
| EPS Diluted | 62.00% | 25.43% | 54.53% | 79.91% | -27.15% |
| Normalized Diluted EPS | 62.02% | 25.51% | 54.51% | 79.90% | -27.11% |
| Average Basic Shares Outstanding | 134.70% | 133.24% | 125.70% | 64.44% | 17.70% |
| Average Diluted Shares Outstanding | 134.70% | 133.24% | 125.70% | 64.44% | 17.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |